The Anti-Falsification Directive: Europe’s Answer to Global Supply Chain Threats
By
Bowman Cox / Email the Author / “The Gold Sheet” July 2011, Vol. 45, No. 7
Word Count: 3258 / Article # 08110701005
Executive Summary
The European Union July 1 published its directive on falsified medicines, setting into motion a tightening of Europe’s pharmaceutical supply chain that will for the most part take place over the next 18 months – and that could cost pharmaceutical companies billions of Euros.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.